Dugo, Clementina

Dugo, Clementina  

Mostra records
Risultati 1 - 7 di 7 (tempo di esecuzione: 0.01 secondi).
Titolo Data di pubblicazione Autore(i) File
Association between higher serum uric acid levels and plasma N-terminal pro-B-type natriuretic peptide concentrations in patients with coronary artery disease and without overt heart failure 1-gen-2022 Mantovani, Alessandro; Bonapace, Stefano; Dugo, Clementina; Beatrice, Giorgia; Petracca, Graziana; Cappelli, Davide; Csermely, Alessandro; Molon, Giulio; Targher, Giovanni
Association between increased plasma ceramides and chronic kidney disease in patients with and without ischemic heart disease 1-gen-2021 Mantovani, A; Lunardi, G; Bonapace, S; Dugo, C; Altomari, A; Molon, G; Conti, A; Bovo, C; Laaksonen, R; Byrne, C D; Bonnet, F; Targher, G
Association between plasma ceramides and inducible myocardial ischemia in patients with established or suspected coronary artery disease undergoing myocardial perfusion scintigraphy 1-gen-2018 Mantovani, Alessandro; Bonapace, Stefano; Lunardi, Gianluigi; Salgarello, Matteo; Dugo, Clementina; Canali, Guido; Byrne, Christopher D; Gori, Stefania; Barbieri, Enrico; Targher, Giovanni
Association of Plasma Ceramides With Myocardial Perfusion in Patients With Coronary Artery Disease Undergoing Stress Myocardial Perfusion Scintigraphy 1-gen-2018 Mantovani, Alessandro; Bonapace, Stefano; Lunardi, Gianluigi; Salgarello, Matteo; Dugo, Clementina; Gori, Stefania; Barbieri, Enrico; Verlato, Giuseppe; Laaksonen, Reijo; Byrne, Christopher D; Targher, Giovanni
Associations between specific plasma ceramides and severity of coronary-artery stenosis assessed by coronary angiography 1-gen-2020 Mantovani, A; Bonapace, S; Lunardi, G; Canali, G; Dugo, C; Vinco, G; Calabria, S; Barbieri, E; Laaksonen, R; Bonnet, F; Byrne, C D; Targher, G
Ceramides and risk of major adverse cardiovascular events: A meta-analysis of longitudinal studies 1-gen-2020 Mantovani, Alessandro; Dugo, Clementina
Hyperuricemia is associated with an increased prevalence of paroxysmal atrial fibrillation in patients with type 2 diabetes referred for clinically indicated 24-h Holter monitoring 1-gen-2018 Mantovani, Alessandro; Rigolon, R; Civettini, A; Bolzan, B; Morani, G; Bonapace, S; Dugo, Clementina; Zoppini, G; Bonora, E; Targher, G